DDX5 Silencing Suppresses the Migration of Basal cell Carcinoma Cells by Downregulating JAK2/STAT3 Pathway

Zhe Quan1, Bei-Bei Zhang1, Fang Yin1

  • 1Department of Dematology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Insights

DEAD (Asp-Glu-Ala-Asp) box protein 5 promotes basal cell carcinoma growth and invasion. Inhibiting this protein and the JAK2/STAT3 pathway may offer new therapeutic strategies for basal cell carcinoma.

Area of Science:

  • Oncology
  • Molecular Biology

Background:

  • Basal cell carcinoma (BCC) pathogenesis involves aberrant hedgehog signaling.
  • DEAD (Asp-Glu-Ala-Asp) box protein 5 (DDX5) is overexpressed in cancers, correlating with tumor progression.

Purpose of the Study:

  • To investigate the role of DDX5 in BCC cell growth, migration, and invasion.
  • To explore the association between DDX5 and the JAK2/STAT3 pathway in BCC.

Main Methods:

  • Quantitative real-time PCR and Western blot to assess DDX5 expression.
  • Terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick-end labeling (TUNEL) assay for apoptosis.
  • Analysis of JAK2/STAT3 pathway modulation following DDX5 knockdown and JAK2 inhibition.

Main Results:

  • DDX5 is significantly overexpressed in BCC cells.
  • DDX5 knockdown suppressed BCC cell migration and invasion and enhanced tunicamycin-induced apoptosis.
  • DDX5 silencing upregulated JAK2 and STAT3 expression; JAK2 inhibition reduced STAT3 levels and reversed DDX5 knockdown's anti-migratory/invasive effects.

Conclusions:

  • DDX5 promotes BCC cell proliferation, migration, and invasion.
  • DDX5 may exert its effects by modulating the JAK2/STAT3 pathway.
  • DDX5 represents a potential therapeutic target for BCC treatment via JAK2/STAT3 pathway downregulation.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Cell Migration01:19

Cell Migration

Cell migration is a process by which the cells move from one location to another, playing an essential role in embryological development, repair and regeneration, immune response, and metastasis. Cells migrate in response to chemical or mechanical signals generated by specific organs or tissues. The overall mechanism includes three steps - polarization, protrusion, and release. Polarization involves the formation of a distinct cell front and rear, which determines the direction of movement.
6.2K
Cell Migration01:09

Cell Migration

Cell migration, the process by which cells move from one location to another, is essential for the proper development and viability of organisms throughout their life. When cells are not able to migrate properly to their ordained locations, various disorders may occur. For example, disruption in cell migration causes chronic inflammatory diseases such as arthritis.
18.4K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.1K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
11.6K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K